Literature DB >> 9824499

Immunosuppressant deoxyspergualin induces apoptotic cell death in dividing cells.

C Odaka1, E Toyoda, K Nemoto.   

Abstract

Deoxyspergualin (DSG) has been found to have an antitumour and immunosuppressive activity. However, the precise mechanism of action of DSG has not been clarified. We have used its analogue, methyldeoxyspergualin (MeDSG) for in vitro culture studies of DSG since it shows good stability in aqueous solution and retains strong immunosuppressive activity. In the present study, we found that MeDSG inhibited proliferation of rapidly dividing murine T-cell hybridomas, resulting in cell death. The cell death was accompanied by chromatin condensation and DNA cleavage at the linker regions between nucleosomes. Furthermore, MeDSG induced a reduction in mitochondrial transmembrane potential. When murine thymocytes were treated with MeDSG for 48 hr, a slight increase of DNA fragmentation was constantly observed, and selective depletion of CD4- CD8- cells was noticed. In contrast, CD4+ CD8+ cells were hardly affected. Moreover, splenic T-cells are resistant to MeDSG-induced apoptosis, as evaluated by measuring DNA cleavage. Our findings may account for the immunosuppressive and antitumour properties of DSG which were described in a number of previous studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9824499      PMCID: PMC1364402          DOI: 10.1046/j.1365-2567.1998.00606.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  39 in total

1.  The effects of deoxyspergualin on lymphocytes and monocytes in vivo and in vitro.

Authors:  P G Kerr; R C Atkins
Journal:  Transplantation       Date:  1989-12       Impact factor: 4.939

2.  Blastogenic responses and the release of interleukins 1 and 2 by spleen cells obtained from rat skin allograft recipients administered with 15-deoxyspergualin.

Authors:  K Nemoto; F Abe; T Nakamura; M Ishizuka; T Takeuchi; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1987-07       Impact factor: 2.649

3.  ATP depletion inhibits glucocorticoid-induced thymocyte apoptosis.

Authors:  C Stefanelli; F Bonavita; I Stanic'; G Farruggia; E Falcieri; I Robuffo; C Pignatti; C Muscari; C Rossoni; C Guarnieri; C M Caldarera
Journal:  Biochem J       Date:  1997-03-15       Impact factor: 3.857

4.  Suppression of tissue graft rejection by spergualin.

Authors:  H Umezawa; M Ishizuka; T Takeuchi; F Abe; K Nemoto; K Shibuya; T Nakamura
Journal:  J Antibiot (Tokyo)       Date:  1985-02       Impact factor: 2.649

5.  Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation.

Authors:  A H Wyllie
Journal:  Nature       Date:  1980-04-10       Impact factor: 49.962

6.  Mechanism of action of 15-deoxyspergualin. I. Suppressive effect on the induction of alloreactive secondary cytotoxic T lymphocytes in vivo and in vitro.

Authors:  K Nishimura; T Tokunaga
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

7.  Decrease of mononuclear phagocyte cell functions and prolongation of graft survival in experimental transplantation by (+/-)-15-deoxyspergualin.

Authors:  G Dickneite; H U Schorlemmer; H H Sedlacek
Journal:  Int J Immunopharmacol       Date:  1987

8.  Effect of spergualin in autoimmune disease mice.

Authors:  K Nemoto; M Hayashi; J Ito; F Abe; T Takita; T Nakamura; T Takeuchi; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1987-10       Impact factor: 2.649

9.  Cytotoxicity of spergualin and amine oxidase activity in medium.

Authors:  S Kunimoto; K Miura; H Iinuma; T Takeuchi; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1985-07       Impact factor: 2.649

10.  In vitro immunosuppressive properties of spergualins to murine T cell response.

Authors:  H Fujii; T Takada; K Nemoto; F Abe; A Fujii; T Takeuchi
Journal:  J Antibiot (Tokyo)       Date:  1989-05       Impact factor: 2.649

View more
  1 in total

1.  In vivo effects of cyclic administration of 15-deoxyspergualin on leucocyte function in patients with Wegener's granulomatosis.

Authors:  A-I Kälsch; W H Schmitt; A Breedijk; S Marinaki; S Weigerding; T C Nebe; K Nemoto; F J van der Woude; B A Yard; R Birck
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.